8 completed. 8 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
Follow Acarbose: new trials by email Literature Review of Acarbose trials Research Report on Acarbose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CGM-Guided Acarbose for Painful Diabetic Neuropathy Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications | Phase 1 | Completed | Shifa International Hospital | 170 | 2025-09-01 | 2026-03-03 |
| Bioequivalence Study for Acarbose/Metformin FDC Acarbose/Metformin FDC(BAY81-9783), Glucobay, Glucophage - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Bayer | 24 | 2019-10-14 | 2020-04-13 |
| Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Exenatide, Acarbose, Exenatide Placebo - Hyperinsulinemic Hypoglycemia | Phase 1 | Completed | University of Minnesota | 11 | 2016-02-01 | 2021-05-06 |
| Bioequivalence Study for Acarbose / Metformin FDC Acarbose/Metformin FDC (BAY81-9783), Acarbose (Glucobay, BAYG5421), Metformin - Diabetes Mellitus, Type II | Phase 1 | Completed | Bayer | 40 | 2012-09-01 | 2012-12-19 |
| A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg Acarbose (Glucobay ODT, BAYG5421), Acarbose (Glucobay, BAYG5421) - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Bayer | 34 | 2012-03-01 | 2013-06-14 |
| A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet Acarbose (Glucobay ODT, BAYG5421), Acarbose (Glucobay, BAYG5421) - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Bayer | 33 | 2011-06-01 | 2013-08-28 |
| Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers BI 44847, Acarbose, Japanese diet - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 37 | 2008-10-01 | 2014-08-08 |
| Treatment of Orthostatic Hypotension in Autonomic Failure Atomoxetine, Acarbose, Pyridostigmine Bromide - Autonomic Failure, Orthostatic Hypotension | Phase 1 | Completed | Vanderbilt University | 389 | 2002-03-01 | 2017-01-18 |
Diabetes Mellitus, Type 2 (4) · Congenital Hyperinsulinism (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Neuropathies (1) · Hypotension, Orthostatic (1) · Pain (1) · Pure Autonomic Failure (1)
Bayer (4) · Boehringer Ingelheim (1) · Shifa International Hospital (1) · University of Minnesota (1) · Vanderbilt University (1)
Germany (2) · United States (2) · China (1) · Pakistan (1) · South Korea (1)
Italo Biaggioni, MD (1) · Shalamar D Sibley, MD (1)
PMID 10662747, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12832331, PMID 15066944, PMID 15710782, PMID 15738343, PMID 17515447, PMID 17515448, PMID 20837887, PMID 22311903, PMID 27271310, PMID 39727053, PMID 9727818